Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension.
about
Surgical technique for the treatment of renal cell carcinoma with inferior vena cava tumor thrombus: tips, tricks and oncological resultsManagement of inferior vena cava tumor thrombus in locally advanced renal cell carcinomaImpact of an altered PROX1 expression on clinicopathology, prognosis and progression in renal cell carcinoma.Impact of miR-21, miR-126 and miR-221 as prognostic factors of clear cell renal cell carcinoma with tumor thrombus of the inferior vena cava.Tumor thrombus of inferior vena cava in patients with renal cell carcinoma - clinical and oncological outcome of 50 patients after surgery.Delta-like ligand 4: A predictor of poor prognosis in clear cell renal cell carcinomaPrognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center.UBE3C promotes growth and metastasis of renal cell carcinoma via activating Wnt/β-catenin pathway.Clinical and oncological outcomes in Chinese patients with renal cell carcinoma and venous tumor thrombus extension: single-center experience.Validation of the 2009 TNM Classification for Renal Cell Carcinoma: Comparison with the 2002 TNM Classification by Concordance Index.Clinical and prognostic factors for renal parenchymal, pelvis, and ureter cancers in SEER registries: collaborative stage data collection system, version 2Low expression of phosphatase and tensin homolog in clear‑cell renal cell carcinoma contributes to chemoresistance through activating the Akt/HDM2 signaling pathway.Prognostic markers in renal cell carcinoma: A focus on the 'mammalian target of rapamycin' pathwayPrognostic Outcomes and Risk Factors for Patients with Renal Cell Carcinoma and Venous Tumor Thrombus after Radical Nephrectomy and Thrombectomy: The Prognostic Significance of Venous Tumor Thrombus LevelMulti-disciplinary surgical approach to the management of patients with renal cell carcinoma with venous tumor thrombus: 15 year experience and lessons learnedCD147 and Prostate Cancer: A Systematic Review and Meta-Analysis.Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of UpstagingRenal cell carcinoma with metachronous metastasis to the contralateral adrenal gland and urinary bladder: A case report.Prognostic role of PPAR-γ and PTEN in the renal cell carcinoma.The Prognostic Impact of a Positive Vascular Margin on pT3 Clear Cell Renal Cell CarcinomaExtent of renal vein invasion influences prognosis in patients with renal cell carcinoma.Novel Use of AngioVac System to Prevent Pulmonary Embolism during Radical Nephrectomy with Inferior Vena Cava ThrombectomyNuclear Magnetic Resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma.Cytoreductive nephrectomy with thrombectomy before targeted therapy improves survival for metastatic renal cell carcinoma with venous tumor thrombus: a single-center experience.Effect of perineoplasm perinephric adipose tissues on migration of clear cell renal cell carcinoma cells: a potential role of WNT signaling.Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy.Development of a surgical safety checklist for the performance of radical nephrectomy and tumor thrombectomy.The circadian clock and the hypoxic response pathway in kidney cancer.Improving surgical outcomes in renal cell carcinoma involving the inferior vena cava.Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).Caval thrombus in conjunction with renal tumors: indication for surgery and technical details.Prognostic factor for Korean patients with renal cell carcinoma and venous tumor thrombus extension: application of the new 2009 TNM staging system.Nephrectomy and inferior vena cava thrombectomy for renal cell carcinoma among patients with impaired renal function: defining predictors of outcomes.Intrinsic gene changes determine the successful establishment of stable renal cancer cell lines from tumor tissue.Postoperative recurrence of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.Management of IVC Thrombus-Surgical Strategies and Outcomes.Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinoma-A finding with therapeutic potential.A proposal of post-operative nomogram for overall survival in patients with renal cell carcinoma and venous tumor thrombus.Recurrence pattern in patients with locally advanced renal cell carcinoma: The implications of clinicopathological variables.
P2860
Q26765075-95F96B4A-C67A-48CD-8AE2-DF24C5C4211CQ26786534-3C208821-CAEC-4CA6-A7A9-F3DF60B2E822Q33567647-C26FBA30-47FA-4DE1-8E26-2FCBCA4C6373Q34287632-6D3682A6-A253-4712-A36A-32DBFD7F6061Q34289618-881A4381-6653-4DC8-8B48-0B2F2CAB3904Q34427294-158D91F6-ADC7-4371-8A7F-84BC85D70A84Q35017319-055B2370-22B6-471A-8C17-8584B0E237EEQ35058286-DF60CA28-A747-47EC-A9ED-262FAD906BF0Q35096601-F82BAF7E-281C-4375-AC6A-AF95F47C8AF4Q35182385-881223E8-6866-4DDF-AA8C-4985DE4ED841Q35439990-531BEF5C-E72E-48D3-A2E0-89E2F937CDAEQ35728921-79F7B1A6-5A50-4736-A89A-8DB5CF154B83Q35838273-38B54BC1-2CE4-4735-A393-D5D9942A2DD7Q36068632-392960EB-C9DA-4096-8306-C7529E43A28BQ36082151-963F3761-40DF-4E21-AEF9-92F5AC3CD91DQ36148171-88E2B59E-4EEC-4C56-A18D-E178258A0EE1Q36197166-A2FDC70F-EBC1-446B-8F68-DBB7EA251D41Q36336297-E8C6811F-2BF0-49D6-B321-D55A35BBDF20Q36375196-EB0B2EBC-4290-4FAA-83CB-E424A4808084Q36563674-96117ED6-7303-4658-9C34-FBADF1E3B3DFQ36788797-E4C9842A-4CBC-4C56-945E-896C3B70E479Q37198078-5FA6C6FE-46E6-4B5D-9D94-5B6E18224B9FQ37421650-6247B9B8-673C-47AF-8273-CB8E572559D0Q37566643-78D9EC16-1D17-4CD2-9947-8408A9F39F57Q37619739-54D5C9F2-0E24-485D-B431-324BA62967A7Q38004096-277744CD-3F7E-44EA-852B-5F0B0BE99379Q38067518-8AF29C2D-66A4-4A5A-B897-3CF9F8D3A2FBQ38128792-462DC316-46CD-4B75-8C19-2578661FFF46Q38162922-319CE79D-A716-4C3B-9503-92FC6ADA695EQ38200568-B2C0C418-8A4D-4465-BB15-F560A51CD56CQ38252388-56665DA8-9676-426B-9E7A-996CF2351BA3Q38448740-627B4A16-73B7-4079-8A42-1C63E49BF12AQ38586908-8162A6D9-0414-4B8C-92BA-58B310B671F9Q38714028-95912829-265D-4979-AF62-3F9CF87FCF14Q38740145-823420BD-F2FB-4D36-92F1-2AFAE786D726Q38853863-19DB9B7F-924E-4A36-8A37-0E599BF20C43Q39331526-37F190D3-3CD2-4487-8EFB-A3B3491D506AQ39395931-30AA2A54-1C3C-48CF-A3DB-0717F2777E49Q40322354-D4A10DC2-00E1-4773-A211-E990501DDBE3Q40333846-B7530B23-1FDF-4ED6-89DD-6689FE2B5691
P2860
Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prognostic impact of the 2009 ...... rcinoma with venous extension.
@en
Prognostic impact of the 2009 ...... rcinoma with venous extension.
@nl
type
label
Prognostic impact of the 2009 ...... rcinoma with venous extension.
@en
Prognostic impact of the 2009 ...... rcinoma with venous extension.
@nl
prefLabel
Prognostic impact of the 2009 ...... rcinoma with venous extension.
@en
Prognostic impact of the 2009 ...... rcinoma with venous extension.
@nl
P2093
P50
P1433
P1476
Prognostic impact of the 2009 ...... rcinoma with venous extension.
@en
P2093
Alessandro Volpe
Axel Haferkamp
Carlo Terrone
Carlos Hernández
Claudio Martínez-Ballesteros
Felipe Herranz
Fernando J Bianco
Gaetano Ciancio
Humberto Villavicencio
P304
P356
10.1016/J.EURURO.2010.10.001
P407
P577
2010-10-13T00:00:00Z